LabCompass

Tahreem Zaheer

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
vaccines and immunoinformatics approachesAntibiotic Resistance in BacteriaSARS-CoV-2 and COVID-19 ResearchMosquito-borne diseases and controlComputational Drug Discovery Methods

Publications

32

Citations

472

Est. group size

—

Recurring co-author estimate

Active years

11

Publishing since 2016

Research summary
AI-generated

Tahreem Zaheer works in computational biology, using software tools and machine learning to design vaccines and identify drug targets against infectious diseases. Much of this work involves analyzing microbial genomes to find candidate molecules (epitopes and antigens) that could form the basis of new vaccines for pathogens such as HIV, E. coli, tuberculosis bacteria, and SARS-CoV-2. The research also examines antibiotic resistance in bacteria through genome sequencing.

Computer-based (in silico) vaccine designImmunoinformatics and epitope predictionBacterial genomics and antibiotic resistanceComputational drug discoveryCOVID-19 and viral disease research

Publication activity has grown over the past decade, rising from one or two papers per year early on to a peak of seven in 2023 and a steady output averaging around four per year recently.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.0/year recently
2017: 1 publication172018: 2 publications182019: 2 publications192020: 5 publications202021: 1 publication212022: 2 publications222023: 7 publications7232024: 5 publications24252026: 6 publications26
Recent publications
Publishes in
  • Elsevier eBooks×5
  • BENTHAM SCIENCE PUBLISHERS eBooks×4
  • Zenodo (CERN European Organization for Nuclear Research)×4
  • Current Proteomics×2
  • Open MIND×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile